Bucillamine - CAS 65002-17-7

Bucillamine (DE019) protects against Ischemia/reperfusion injury in high-risk organ transplants and inhibits the production of VEGF. Bucillamine is an orally active sulfhydryl donor and antioxidant with antirheumatic and antiangiogenic properties. Bucillamine can be used for studies about choroidal neovascularization and rheumatoid arthritis.

VEGFR, Antioxidant

Angiogenesis, Tyrosine Kinase/Adaptors, Oxidation-Reduction

64978

0.9947

C7H13NO3S2

223.31

[C@@H](NC(C(C)(C)S)=O)(C(O)=O)CS

-20°C

Ice Packs

Small Compound